| P2093 | author name string | Andreas H Wagner | |
| | Thomas Korff | |
| | Carsten Sticht | |
| | Markus Hecker | |
| | Caroline Arnold | |
| | Hanna Kuk | |
| P2860 | cites work | A matrix metalloproteinase expressed on the surface of invasive tumour cells | Q24312733 |
| | Revision of the CEAP classification for chronic venous disorders: consensus statement | Q28300287 |
| | Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1 | Q28570672 |
| | Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro. | Q52952706 |
| | Experimental hypertension triggers varicosis-like maladaptive venous remodeling through activator protein-1. | Q53239684 |
| | Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies | Q69665015 |
| | Cyclic strain causes heterogeneous induction of transcription factors, AP-1, CRE binding protein and NF-kB, in endothelial cells: species and vascular bed diversity | Q71151146 |
| | World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects | Q73135842 |
| | Morphologic characteristics of varicose veins: possible role of metalloproteinases | Q73618854 |
| | The development of collateral circulation in the mouse's ear | Q78375138 |
| | Matrix metalloproteinases in the vein wall | Q80914344 |
| | Inhibitory effects of triterpenes and flavonoids on the enzymatic activity of hyaluronic acid-splitting enzymes | Q83828057 |
| | Junctional and nonjunctional effects of heptanol and glycyrrhetinic acid derivates in rat mesenteric small arteries | Q35047408 |
| | Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway | Q35073336 |
| | 18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer | Q35138733 |
| | Varicose veins: role of mechanotransduction of venous hypertension. | Q35829875 |
| | Management of reticular veins and telangiectases | Q35837999 |
| | Effects of topical application of B-Resorcinol and Glycyrrhetinic acid monotherapy and in combination with fractional CO2 laser treatment for benign hand hyperpigmentation treatment. | Q36057364 |
| | Electrical conduction along endothelial cell tubes from mouse feed arteries: confounding actions of glycyrrhetinic acid derivatives | Q36159248 |
| | Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells | Q36685537 |
| | Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors | Q36714057 |
| | Involvement of gap junctions between smooth muscle cells in sustained hypoxic pulmonary vasoconstriction development: a potential role for 15-HETE and 20-HETE | Q36811256 |
| | Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins | Q36953739 |
| | Mechanisms of varicose vein formation: valve dysfunction and wall dilation | Q37153376 |
| | Cyclic stretch induces cyclooxygenase-2 gene expression in vascular endothelial cells via activation of nuclear factor kappa-beta | Q37390752 |
| | Varicose veins and chronic venous insufficiency | Q37649602 |
| | Atopic dermatitis: an evidence-based treatment update. | Q38182048 |
| | Pathogenesis of varicose veins - lessons from biomechanics | Q38195809 |
| | Sclerotherapy of telangiectasias or spider veins in the lower limb: A review | Q38841092 |
| | 18β-Glycyrrhetinic acid suppresses TNF-α induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-κB pathway | Q39016923 |
| | Glycyrrhetinic acid inhibits ICAM-1 expression via blocking JNK and NF-kappaB pathways in TNF-alpha-activated endothelial cells | Q39018324 |
| | Prevalence and risk factors of varicose veins in lower extremities: mini-Finland health survey. | Q39371466 |
| | Anatomy of the Superficial Venous System | Q40437896 |
| | The protective effect of 18β-Glycyrrhetinic acid against UV irradiation induced photoaging in mice | Q41700859 |
| | Lower extremity venous anatomy | Q41893599 |
| | Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear oedema | Q42848271 |
| | Glycyrrhetinic acid attenuates vascular smooth muscle vasodilatory function in healthy humans. | Q43048882 |
| | Bortezomib protects from varicose-like venous remodeling | Q44580587 |
| | Synthesis of new glycyrrhetinic acid (GA) derivatives and their effects on tyrosinase activity | Q44671737 |
| | Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application | Q46490629 |
| | Glycyrrhetinic acid prevents cutaneous scratching behavior in mice elicited by substance P or PAR-2 agonist | Q46528396 |
| | An animal model of venous hypertension: the role of inflammation in venous valve failure | Q46716828 |
| | HMG-CoA reductase inhibitors reduce matrix metalloproteinase-9 activity in human varicose veins | Q46933301 |
| | Magnolol inhibits venous remodeling in mice | Q47103261 |
| | Inhibition of mutagenicity in Salmonella typhimurium and skin tumor initiating and tumor promoting activities in SENCAR mice by glycyrrhetinic acid: comparison of 18 alpha- and 18 beta-stereoisomers. | Q50189733 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 320 | |
| P577 | publication date | 2018-04-04 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | Glycyrrhetinic Acid Antagonizes Pressure-Induced Venous Remodeling in Mice. | |
| P478 | volume | 9 | |